(Q38078565)

English

Relevance of the type I interferon signature in multiple sclerosis towards a personalized medicine approach for interferon-beta therapy.

scientific article published on January 2013

In more languages

default for all languages

No label defined

No description defined

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23375014

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23375014%20AND%20SRC:MED&resulttype=core&format=json

retrieved

23 February 2020

review article

1 reference

stated in

Europe PubMed Central

title

Relevance of the type I interferon signature in multiple sclerosis towards a personalized medicine approach for interferon-beta therapy (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23375014

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23375014%20AND%20SRC:MED&resulttype=core&format=json

retrieved

23 February 2020

main subject

multiple sclerosis

0 references

personalized medicine

1 reference

1

Cornelis L Verweij

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23375014

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23375014%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

2

Saskia Vosslamber

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23375014

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23375014%20AND%20SRC:MED&resulttype=core&format=json

retrieved

23 February 2020

publication date

1 January 2013

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23375014

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23375014%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

1 reference

Europe PubMed Central

PubMed publication ID

23375014

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23375014%20AND%20SRC:MED&resulttype=core&format=json

retrieved

23 February 2020

volume

15

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23375014

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23375014%20AND%20SRC:MED&resulttype=core&format=json

retrieved

23 February 2020

issue

80

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23375014

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23375014%20AND%20SRC:MED&resulttype=core&format=json

retrieved

23 February 2020

page(s)

51-60

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23375014

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23375014%20AND%20SRC:MED&resulttype=core&format=json

retrieved

23 February 2020

Identifiers

PubMed publication ID

23375014

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23375014

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23375014%20AND%20SRC:MED&resulttype=core&format=json

(Q38078565)

Relevance of the type I interferon signature in multiple sclerosis towards a personalized medicine approach for interferon-beta therapy.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)